Korea Bioethics Act A Drag On Gene Therapies?
This article was originally published in PharmAsia News
Executive Summary
To create an environment in which South Korea can become a leader in the gene therapy space, an industry expert has called for the government to ease regulations by revising relevant laws, saying excessive regulations are dragging down development efforts by venture capital-backed firms.